ADHD Medication After a Diagnosis: How Telehealth Prescribing Works in 2026

A diagnosis and a prescription are two different steps

An ADHD evaluation answers a question: do this person's difficulties fit ADHD, and what else might explain them? It ends with findings and recommendations. It does not end with a prescription, because writing one is a separate medical decision.

That decision belongs to a prescriber. The National Institute of Mental Health (NIMH) notes that primary care providers sometimes diagnose and treat ADHD, or refer a person to a mental health professional. A prescriber looks at your health history, other conditions and other medicines before deciding whether medication makes sense for you.

NIMH also says treatment for ADHD often combines elements: medication, psychotherapy and other behavioral supports. Some people use medication, some do not, and many use skills-based therapy either way.

Why ADHD medicines come with extra rules

According to NIMH, stimulants are the most common type of medication used to treat ADHD, and like all medicines they can have side effects and must be prescribed and monitored by a health care provider. Sometimes a person tries several medicines or doses before finding one that works for them.

Many stimulants are controlled substances. Federal regulations list several of the stimulants used for ADHD in Schedule II, the most tightly controlled group of prescription medicines. MedlinePlus, from the National Library of Medicine, describes one commonly prescribed ADHD stimulant as a central nervous system stimulant and warns that it can be habit-forming.

These rules shape everyday care. MedlinePlus notes that a prescription for that medicine is not refillable and that people should schedule regular appointments so they do not run out. That is one reason a steady relationship with one prescriber matters.

The federal telehealth rule, as of October 2026

Under a federal law called the Ryan Haight Act, a practitioner generally may prescribe a controlled substance remotely only after at least one in-person medical evaluation of the patient, with certain exceptions. During the COVID-19 public health emergency, the Drug Enforcement Administration (DEA) granted temporary exceptions, often called the telemedicine flexibilities. DEA and the Department of Health and Human Services (HHS) have extended them together since.

Those flexibilities have been extended several times. The latest, the Fourth Temporary Extension, was published in the Federal Register on December 31, 2025, and is effective from January 1, 2026 through December 31, 2026. HHS's telehealth site says that under it, a DEA-registered practitioner can prescribe a Schedule II to V controlled substance by telemedicine without having conducted an in-person medical evaluation, if required conditions are met.

The rule describes these as audio-video telemedicine encounters, and prescriptions must still comply with DEA regulations and applicable federal and state law. In January 2025, DEA proposed a separate special registration for telemedicine, and the extension says it gives DEA time to finalize permanent rules.

What to bring to a prescriber

A first visit goes further when the prescriber has the full picture. It can help to ask the office ahead of time what they would like you to send or bring.

1. 1Your evaluation reportBring or send a copy of the written report, and ask whether the prescriber needs anything else from the evaluator. We cannot say whether a given prescriber will accept a report, so ask first.
2. 2A full list of what you takeMedlinePlus advises keeping a written list of all prescription and over-the-counter medicines, vitamins and supplements and bringing it to each visit. NIMH notes that some medicines can interact with stimulants.
3. 3Your health historyFor one common ADHD stimulant, MedlinePlus lists things to tell a doctor first, including any personal or family history of heart problems, high blood pressure, tics, and mental health conditions such as depression. Past medicines that did or did not help are worth noting too.
4. 4Your questionsFor example: Do you see patients by telehealth for this? Will you need to see me in person at any point? How often will we meet? What should I do if I notice side effects?

Therapy can be part of the plan, with or without medication

NIMH describes cognitive behavioral therapy for ADHD as helping a person become aware of attention and concentration challenges and build skills for focus, organization and daily tasks, such as breaking large tasks into smaller steps. It adds that therapy can be especially helpful when ADHD occurs alongside anxiety or depression.

NIMH also says adding therapy to an ADHD treatment plan can help some people cope with daily challenges and gain confidence. That holds whatever you and your prescriber decide about medication.

How we can help

Locascio Wellness does not prescribe medication and does not give medication advice. What we offer is the step before and the support around it. Our ADHD evaluation ends with the findings explained in plain language and a written report you can share with your own prescriber. Evaluations are private-pay with a sliding scale, and you can read about what evaluations cost.

Evaluations and therapy are by secure video for people physically located in Pennsylvania, West Virginia or Arizona. Therapists on our team offer ADHD therapy as ongoing support. To start, use the short evaluation request form or book a free 15-minute consultation on our booking page.

If you are in crisis, call or text 988, or call 911. Locascio Wellness does not provide emergency services.